Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CK Nutraceuticals is a prominent North American supplier of science-based, value-added ingredients for the dietary supplement and functional food industries. The company focuses on providing proprietary, clinically-supported raw materials that address specific health concerns such as cognitive health, stress management, and women's wellness. Their portfolio features well-recognized branded ingredients, including Zembrin for mood support and EstroG-100 for menopausal symptoms. Headquartered in Ontario, Canada, the company emphasizes quality assurance and regulatory compliance to support its B2B clients. In late 2022, CK Nutraceuticals was acquired by LBB Specialties, a leader in North American specialty chemical and ingredient distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CK Nutraceuticals.